| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |